Table 2 Comparison of demographic and clinical data between the two groups
Variables | Group I (preoperative LVEF > 35), N = 76 (69%) | Group II (preoperative LVEF < 35), N = 34 (31%) | p value |
|---|---|---|---|
Age > 65 | 27 (35.5%) | 9 (26.5%) | 0.350 |
DM | 57 (75.0%) | 31 (91%) | 0.05 |
HTN | 57 (75.0%) | 26 (76%) | 0.117 |
Smoking | 32 (42.1%) | 12 (35.3%) | 0.500 |
Dyslipidemia | 42 (56.8%) | 15 (45.5%) | 0.279 |
CKD | 11 (14.5%) | 7 (20.6%) | 0.423 |
Obesity | 33 (43.4%) | 19 (55.9%) | 0.226 |
OLD IHD | 56 (73.7%) | 27 (79.4%) | 0.519 |
High BNP | 19 (55.9%) | 9 (75.0%) | 0.243 |
NEHA class II/III | 57 (75%) | 26 (76%) | 0.117 |
Standard Euro SCORE | 6 (4-8) | 8 (6–10) | < 0.001 |
High TROPONIN | 64 (84.2%) | 34 (100%) | 0.014 |
High Initial SCR | 19 (25.0%) | 8 (23.5%) | 0.868 |
Dilated LV | 8 (10.5%) | 7 (20.6%) | 0.155 |
Diastolic dysfunction | 26 (34.1%) | 21 (61.7%) | 0.025 |
Dilated LA | 10 (13.2%) | 5 (14.7%) | 0.827 |
Dilated RA | 3 (3.9%) | 0 (0.0%) | 0.240 |
Dilated RV size | 6 (8.0%) | 3 (8.8%) | 0.885 |
MR | 19 (25.0%) | 12 (35.3%) | 0.267 |
TR | 5 (6.6%) | 4 (11.8%) | 2.688 |
RVD (reduced TAPSE Pre-OP) | 4 (5.3%) | 7 (20.6%) | 0.013 |
LM disease | 11 (14%) | 4 (12%) | 0.76 |
Emergent surgery | 2 (2.6%) | 2 (5.8) | 0.08 |
CABG alone | 59 (78%) | 28 (82%) | – |
CABG + MVR | 17 (22%) | 6 (18%) | – |